US3385756A
(en)
|
1965-06-07 |
1968-05-28 |
Monsanto Co |
Methods of destroying insects with nitro-substituted salicylanilides
|
US3975532A
(en)
|
1973-06-14 |
1976-08-17 |
Ici United States Inc. |
Hexahydro-1H-furo(3,4-c) pyrrole compounds for treating pain
|
DE2853220A1
(de)
|
1978-12-09 |
1980-07-03 |
Hoechst Ag |
Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
|
US4507481A
(en)
|
1983-07-29 |
1985-03-26 |
Pennwalt Corporation |
Pyrrolo[1,2-a]imidazoles and imidazo[1,2-a]pyridines
|
US4917826A
(en)
|
1985-10-18 |
1990-04-17 |
The Upjohn Company |
Cyclic hydrocarbons with an aminoalkyl sidechain
|
US5656644A
(en)
|
1994-07-20 |
1997-08-12 |
Smithkline Beecham Corporation |
Pyridyl imidazoles
|
JP2609434B2
(ja)
|
1992-11-16 |
1997-05-14 |
ボリソビッチ レオニドフ,ニコライ |
抗菌性インターフェロン誘発性医薬品
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
US6420338B1
(en)
|
1997-06-13 |
2002-07-16 |
New York University Medical Center |
Inhibition of the Src kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
|
FR2765577A1
(fr)
|
1997-07-02 |
1999-01-08 |
Hoechst Schering Agrevo Sa |
Nouveaux amides aromatiques, leur procede de preparation et leur application comme pesticides
|
GB9805520D0
(en)
|
1998-03-17 |
1998-05-13 |
Zeneca Ltd |
Chemical compounds
|
DE19817262A1
(de)
|
1998-04-18 |
1999-10-21 |
Bayer Ag |
Neue 2-heterocyclisch substituierte Dihydropyrimidine
|
US6525069B1
(en)
|
1998-12-18 |
2003-02-25 |
Bristol-Myers Squibb Pharma Co. |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
AU5636900A
(en)
|
1999-06-30 |
2001-01-31 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
DE10012549A1
(de)
|
2000-03-15 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
DE10012823A1
(de)
|
2000-03-16 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
DE10013126A1
(de)
|
2000-03-17 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
ES2330719T3
(es)
|
2000-12-28 |
2009-12-15 |
SHIONOGI & CO., LTD. |
Derivados de 2-piridona con afinidad para el receptor cannabinoide de tipo 2.
|
DE10109856A1
(de)
|
2001-03-01 |
2002-09-05 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
AU2003273179A1
(en)
|
2002-05-10 |
2003-12-12 |
Bristol-Myers Squibb Company |
1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
|
BR0312924A
(pt)
|
2002-07-25 |
2005-07-12 |
Pharmacia Italia Spa |
Biciclo-pirazóis ativos como inibidores de quinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos
|
US20050113450A1
(en)
|
2002-08-23 |
2005-05-26 |
Atli Thorarensen |
Antibacterial agents
|
US20040209930A1
(en)
|
2002-10-02 |
2004-10-21 |
Carboni Joan M. |
Synergistic methods and compositions for treating cancer
|
DE10257358A1
(de)
|
2002-12-09 |
2004-07-08 |
Bayer Healthcare Ag |
Substituierte Pyrrole
|
US7232825B2
(en)
|
2003-05-02 |
2007-06-19 |
Guoqing P Chen |
Phenylaminopyrimidine derivatives and methods of use
|
US20050203119A1
(en)
|
2003-09-10 |
2005-09-15 |
Mitsunori Ono |
Dihydropyridine compounds for treating or preventing metabolic disorders
|
ES2562778T3
(es)
|
2003-12-02 |
2016-03-08 |
The Ohio State University Research Foundation |
Ácidos grasos de cadena corta unidos a motivos quelantes de Zn2+ como una clase novedosa de inhibidores de histona deacetilasa
|
BRPI0511834A
(pt)
|
2004-07-14 |
2008-01-08 |
Ptc Therapeutics Inc |
métodos por tratar hepatite c
|
WO2006033995A2
(en)
|
2004-09-16 |
2006-03-30 |
Valeant Research And Development |
Thiazolidin-4-ones having anti-hepatitis b activity
|
AU2006270322A1
(en)
|
2005-07-14 |
2007-01-25 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
CA2620179C
(en)
|
2005-08-16 |
2013-10-29 |
Icagen, Inc. |
Inhibitors of voltage-gated sodium channels
|
US20070219239A1
(en)
|
2006-02-10 |
2007-09-20 |
Mjalli Adnan M |
Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
|
CN103739595A
(zh)
|
2006-10-02 |
2014-04-23 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
WO2008120759A1
(ja)
|
2007-03-30 |
2008-10-09 |
Japan Tobacco Inc. |
ウレア化合物およびその用途
|
BRPI0811516A2
(pt)
|
2007-05-04 |
2014-11-18 |
Irm Llc |
Compostos e composições como inibidores de c-kit e pdgfr cinase
|
TWI394575B
(zh)
|
2007-07-09 |
2013-05-01 |
Golden Biotechnology Corp |
Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for the Suppression of Hepatitis B Virus
|
WO2009012242A2
(en)
|
2007-07-13 |
2009-01-22 |
Icagen, Inc. |
Sodium channel inhibitors
|
CN101765425A
(zh)
|
2007-08-02 |
2010-06-30 |
弗·哈夫曼-拉罗切有限公司 |
苯甲酰胺衍生物用于治疗cns障碍的用途
|
EP2222660B1
(en)
|
2007-11-16 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
3-heterocyclic substituted indole derivatives and methods of use thereof
|
CA2722075C
(en)
|
2008-04-24 |
2015-11-24 |
Banyu Pharmaceutical Co., Ltd. |
Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
|
AU2009262241B2
(en)
|
2008-06-25 |
2014-05-22 |
Forum Pharmaceuticals Inc. |
1, 2 disubstituted heterocyclic compounds
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
WO2010123139A1
(ja)
|
2009-04-24 |
2010-10-28 |
持田製薬株式会社 |
スルファモイル基を有するアリールカルボキサミド誘導体
|
CA2940954A1
(en)
|
2009-05-12 |
2010-11-18 |
Romark Laboratories L.C. |
Nitazoxanide and tizoxanide for the treatment of rhinovirus and rhabdovirus infections
|
WO2011008597A1
(en)
|
2009-07-14 |
2011-01-20 |
Schering Corporation |
Dihydroimidazoisoquinoline derivatives useful as pde10 inhibitors
|
US8377970B2
(en)
|
2009-10-08 |
2013-02-19 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel
|
WO2011143314A1
(en)
|
2010-05-11 |
2011-11-17 |
Arno Therapeutics, Inc |
Compositions and methods for reducing proliferation and viability of lymphoblastoid cells
|
US9399619B2
(en)
|
2011-07-01 |
2016-07-26 |
Baruch S. Blumberg Institute |
Sulfamoylbenzamide derivatives as antiviral agents against HBV infection
|
EP2794565B1
(en)
|
2011-12-21 |
2017-07-26 |
Novira Therapeutics Inc. |
Hepatitis b antiviral agents
|
CN104302626B
(zh)
|
2012-01-06 |
2016-09-07 |
爱尔兰詹森科学公司 |
4,4-二取代的-1,4-二氢嘧啶及其作为治疗乙型肝炎的药物的用途
|
CN108863959B
(zh)
|
2012-01-13 |
2021-11-30 |
日本化学药品株式会社 |
P2x4受体拮抗剂
|
US9657013B2
(en)
|
2012-02-29 |
2017-05-23 |
Baruch S. Blumberg Institute |
Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use
|
RU2014142598A
(ru)
|
2012-03-31 |
2016-05-27 |
Ф. Хоффманн-Ля Рош Аг |
Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
AU2013267209B2
(en)
|
2012-06-01 |
2017-02-02 |
Baruch S. Blumberg Institute |
Modulation of hepatitis B virus cccDNA transcription
|
CN104926808B
(zh)
|
2012-08-24 |
2018-09-14 |
广东东阳光药业有限公司 |
二氢嘧啶类化合物及其在药物中的应用
|
NZ704752A
(en)
|
2012-08-28 |
2018-06-29 |
Janssen Sciences Ireland Uc |
Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
|
CA2881322A1
(en)
|
2012-09-10 |
2014-03-13 |
F. Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
DK2912019T3
(da)
|
2012-10-25 |
2021-05-25 |
Tetra Discovery Partners Llc |
Heteroarylhæmmere af pde4
|
WO2014106019A2
(en)
|
2012-12-27 |
2014-07-03 |
Philadelphia Health & Education Corporation, D/B/A Drexel |
Novel antiviral agents against hbv infection
|
EP2997032B1
(en)
|
2013-05-17 |
2018-07-25 |
F.Hoffmann-La Roche Ag |
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
MX366787B
(es)
|
2013-05-17 |
2019-07-23 |
Janssen Sciences Ireland Uc |
Derivados de sulfamoiltiofenamida y su uso como medicamentos para tratar la hepatitis b.
|
JP6748431B2
(ja)
|
2013-07-12 |
2020-09-02 |
京都ケミカル株式会社 |
抗菌剤、袋入り抗菌剤およびシート型抗菌剤
|
TW201605859A
(zh)
|
2013-11-14 |
2016-02-16 |
必治妥美雅史谷比公司 |
作為酪蛋白激酶1δ/ε抑制劑之新穎經取代之吡唑并-哌
|
AU2014352404B2
(en)
|
2013-11-19 |
2018-07-19 |
Sunshine Lake Pharma Co., Ltd. |
Dihydropyrimidine compounds and their application in pharmaceuticals
|
JP6434511B2
(ja)
|
2013-11-27 |
2018-12-05 |
サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. |
ジヒドロピリミジン誘導体およびその中間体の製造方法
|
WO2015103756A1
(en)
|
2014-01-09 |
2015-07-16 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
EA201691261A1
(ru)
|
2014-01-30 |
2016-11-30 |
Ф. Хоффманн-Ля Рош Аг |
Новые дигидрохинолизиноны для лечения и профилактики инфекции, вызванной вирусом гепатита b
|
EA030115B9
(ru)
|
2014-03-07 |
2018-09-28 |
Ф. Хоффманн-Ля Рош Аг |
Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
|
US9771358B2
(en)
|
2014-03-28 |
2017-09-26 |
Sunshine Lake Pharma Co., Ltd. |
Dihydropyrimidine compounds and their application in pharmaceuticals
|
JP6568106B2
(ja)
|
2014-05-13 |
2019-08-28 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療及び予防のための新規ジヒドロキノリジノン類
|
JP6710642B2
(ja)
|
2014-05-30 |
2020-06-17 |
チル ファーマシューティカル カンパニー リミテッド |
Hbv阻害剤としてのジヒドロピリミジン縮環誘導体
|
CN107001283B
(zh)
|
2014-07-31 |
2021-05-25 |
国家健康与医学研究院 |
Flt3受体拮抗剂
|
BR112017002970B1
(pt)
|
2014-08-14 |
2023-04-11 |
F. Hoffmann-La Roche Ag |
Novas piridazonas e triazinonas para o tratamento e profilaxia da infecção pelo vírus da hepatite b
|
WO2016025933A2
(en)
|
2014-08-15 |
2016-02-18 |
Ptc Therapeutics, Inc. |
Substituted polycyclic antibacterial compounds
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
DK3227262T3
(da)
|
2014-12-02 |
2020-08-10 |
Novira Therapeutics Inc |
Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling
|
JP6506845B2
(ja)
|
2014-12-30 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス感染症の治療及び予防のための新規テトラヒドロピリドピリミジン類及びテトラヒドロピリドピリジン類
|
WO2016109684A2
(en)
|
2014-12-30 |
2016-07-07 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis b infections
|
CN107207505B
(zh)
|
2015-02-11 |
2018-12-14 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的 2-氧代-6,7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
RU2595038C1
(ru)
|
2015-04-03 |
2016-08-20 |
Виктор Вениаминович Тец |
Лекарственное средство с противовирусной активностью (варианты)
|
WO2016177655A1
(en)
|
2015-05-04 |
2016-11-10 |
F. Hoffmann-La Roche Ag |
Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
|
WO2016183266A1
(en)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Ehpatitis b antiviral agents
|
WO2017011552A1
(en)
|
2015-07-13 |
2017-01-19 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
WO2017013046A1
(en)
|
2015-07-21 |
2017-01-26 |
F. Hoffmann-La Roche Ag |
Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
US10301255B2
(en)
|
2015-07-22 |
2019-05-28 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
CN107820496B
(zh)
|
2015-07-27 |
2020-11-03 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四环4-氧代-吡啶-3-甲酸衍生物
|
EP3328858B1
(en)
|
2015-07-28 |
2019-05-15 |
H. Hoffnabb-La Roche Ag |
Novel 6,7-dihydropyrido[2,1-a]phthalazin-2-ones for the treatment and prophylaxis of hepatitis b virus infection
|
EP3360554B1
(en)
|
2015-10-05 |
2021-07-28 |
FUJIFILM Toyama Chemical Co., Ltd. |
Anti-hepatitis b virus agent
|
CN108368113B
(zh)
|
2015-11-04 |
2020-11-24 |
齐鲁制药有限公司 |
二氢吡啶并环化合物的晶型、制备方法和中间体
|
US10280175B2
(en)
|
2016-02-02 |
2019-05-07 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
MX2018010010A
(es)
|
2016-02-19 |
2018-11-09 |
Novartis Ag |
Compuestos tetraciclicos de piridona como antivirales.
|
ES2938341T3
(es)
|
2016-03-07 |
2023-04-10 |
Enanta Pharm Inc |
Agentes antivirales contra la hepatitis B
|
US10858366B2
(en)
|
2016-03-08 |
2020-12-08 |
Novartis Ag |
Tricyclic compounds useful to treat orthomyxovirus infections
|
PL3442947T3
(pl)
|
2016-04-15 |
2023-10-02 |
Epizyme, Inc. |
Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
FR3052452B1
(fr)
|
2016-06-10 |
2018-06-22 |
Les Laboratoires Servier |
Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2017212010A1
(en)
|
2016-06-10 |
2017-12-14 |
Les Laboratoires Servier |
New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
|
SG11201810834WA
(en)
|
2016-06-10 |
2018-12-28 |
Enanta Pharm Inc |
Hepatitis b antiviral agents
|
AR108586A1
(es)
|
2016-06-10 |
2018-09-05 |
Lilly Co Eli |
Compuestos de 2,3-dihidro-1h-indol
|
AU2017277463A1
(en)
|
2016-06-10 |
2019-01-03 |
Bayer As |
Radio-pharmaceutical complexes
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
MA45496A
(fr)
|
2016-06-17 |
2019-04-24 |
Hoffmann La Roche |
Molécules d'acide nucléique pour la réduction de l'arnm de padd5 ou pad7 pour le traitement d'une infection par l'hépatite b
|
JP6742452B2
(ja)
|
2016-06-29 |
2020-08-19 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Hbv感染の処置および予防のための新規のテトラヒドロピリドピリミジン
|
EP3478686B1
(en)
|
2016-06-29 |
2020-04-15 |
H. Hoffnabb-La Roche Ag |
Novel dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
CA3031063A1
(en)
|
2016-07-29 |
2018-02-01 |
Newave Pharmaceutical Inc. |
Benzo-quinolizin-2oxo carboxylic acid derivatives for the treatment of hbv infection
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
WO2018047109A1
(en)
|
2016-09-09 |
2018-03-15 |
Novartis Ag |
Polycyclic pyridone compounds as antivirals
|
WO2018073753A1
(en)
|
2016-10-18 |
2018-04-26 |
Novartis Ag |
Fused tetracyclic pyridone compounds as antivirals
|
EP3535262B1
(en)
|
2016-11-03 |
2020-08-05 |
F. Hoffmann-La Roche AG |
Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
EP3535256B1
(en)
|
2016-11-03 |
2020-12-02 |
F. Hoffmann-La Roche AG |
Novel tetrahydroisoquinolines and terahydronaphthyridines for the treatment and prophylaxis of hepatitis b virus infection
|
EP3535261B1
(en)
|
2016-11-03 |
2020-08-05 |
F. Hoffmann-La Roche AG |
Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US10821103B2
(en)
|
2016-11-07 |
2020-11-03 |
Arbutus Biopharma Corporation |
Substituted pyridinone-containing trycyclic compounds, and methods using same
|
WO2018087345A1
(en)
|
2016-11-14 |
2018-05-17 |
F. Hoffmann-La Roche Ag |
COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
|
AU2018205811B2
(en)
|
2017-01-06 |
2022-02-17 |
Rivus Pharmaceuticals, Inc. |
Novel phenyl derivatives
|
CN106810548B
(zh)
|
2017-01-13 |
2019-02-15 |
苏州爱科百发生物医药技术有限公司 |
一种二氢异喹啉类化合物
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
WO2018154466A1
(en)
|
2017-02-21 |
2018-08-30 |
Glaxosmithkline Intellectual Property Development Limited |
Dihydroquinolizinones as antivirals
|
CN106928245B
(zh)
|
2017-03-06 |
2019-06-11 |
河南春风医药科技有限公司 |
一种喹嗪酮类化合物及其制备方法和应用
|
CN106928215B
(zh)
|
2017-03-06 |
2019-03-22 |
河南春风医药科技有限公司 |
一种喹嗪酮类化合物的制备方法
|
MY174224A
(en)
|
2017-03-09 |
2020-03-23 |
Fujian Cosunter Pharmaceutical Co Ltd |
Hepatitis b virus surface antigen inhibitor
|
EP3604301B1
(en)
|
2017-03-31 |
2021-09-22 |
FUJIFILM Corporation |
4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
|
CN108727378A
(zh)
|
2017-04-19 |
2018-11-02 |
银杏树药业(苏州)有限公司 |
新型异喹啉类化合物及其医药用途
|
AR111419A1
(es)
*
|
2017-04-27 |
2019-07-10 |
Novartis Ag |
Compuestos fusionados de indazol piridona como antivirales
|
JP7145931B2
(ja)
|
2017-04-28 |
2022-10-03 |
斉魯制薬有限公司 |
化合物の結晶多形、その製造方法及び用途
|
CN108530449B
(zh)
*
|
2017-05-22 |
2021-05-07 |
河南春风医药科技有限公司 |
用于治疗或预防乙型肝炎病毒感染的化合物及其制备方法与应用
|
CN110066278B
(zh)
|
2017-06-01 |
2021-06-08 |
广东东阳光药业有限公司 |
稠合三环类化合物及其在药物中的应用
|
EA202090514A1
(ru)
|
2017-08-28 |
2020-06-24 |
Энанта Фармасьютикалс, Инк. |
Противовирусное средство против гепатита в
|
AU2018344926A1
(en)
|
2017-10-05 |
2020-04-16 |
Glaxosmithkline Intellectual Property Development Limited |
Chemical compounds
|
US20210079015A1
(en)
|
2017-11-17 |
2021-03-18 |
Novartis Ag |
Novel dihydroisoxazole compounds and their use for the treatment of hepatitis b
|
EP3694856B1
(en)
|
2017-11-22 |
2023-10-25 |
Sunshine Lake Pharma Co., Ltd. |
Fused tricyclic compounds and uses thereof in medicine
|
GB201720163D0
(en)
|
2017-12-04 |
2018-01-17 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B
|
US10723733B2
(en)
|
2017-12-06 |
2020-07-28 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
TW201927789A
(zh)
|
2017-12-06 |
2019-07-16 |
美商因那塔製藥公司 |
B型肝炎抗病毒試劑
|
WO2019123285A1
(en)
*
|
2017-12-20 |
2019-06-27 |
Novartis Ag |
Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals
|
JP7256810B2
(ja)
|
2017-12-28 |
2023-04-12 |
エフ. ホフマン-ラ ロシュ アーゲー |
B型肝炎ウイルス感染の治療及び予防のためのジヒドロピリミジニルチアゾール
|
US11058678B2
(en)
|
2018-01-22 |
2021-07-13 |
Enanta Pharmaceuticals, Inc. |
Substituted heterocycles as antiviral agents
|
JP2021514982A
(ja)
|
2018-02-28 |
2021-06-17 |
ノバルティス アーゲー |
インドール−2−カルボニル化合物及びb型肝炎治療のためのそれらの使用
|
US10729688B2
(en)
|
2018-03-29 |
2020-08-04 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
MX2020011275A
(es)
|
2018-04-25 |
2020-11-13 |
Bayer Ag |
Novedosos compuestos de heteroaril-triazol y hetroaril[-]tetrazol como plaguicidas.
|
US10865211B2
(en)
|
2018-09-21 |
2020-12-15 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocycles as antiviral agents
|
CN111116577A
(zh)
|
2018-10-30 |
2020-05-08 |
广东东阳光药业有限公司 |
稠合四环类化合物及其在药物中的应用
|
KR20210093951A
(ko)
*
|
2018-11-21 |
2021-07-28 |
이난타 파마슈티칼스, 인코포레이티드 |
항바이러스제로서의 작용화된 헤테로사이클
|
TW202033523A
(zh)
|
2019-01-17 |
2020-09-16 |
美商愛彼特生物製藥股份有限公司 |
經取代的多環羧酸、其類似物及使用其之方法
|
WO2020190740A1
(en)
|
2019-03-15 |
2020-09-24 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for reducing kcnt1 expression
|
US11236108B2
(en)
|
2019-09-17 |
2022-02-01 |
Enanta Pharmaceuticals, Inc. |
Functionalized heterocycles as antiviral agents
|